Novel c-Myc–Targeting Compound N, N-Bis (5-Ethyl-2-Hydroxybenzyl) Methylamine for Mediated c-Myc Ubiquitin-Proteasomal Degradation in Lung Cancer Cells
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Novel c-Myc–Targeting Compound N, N-Bis (5-Ethyl-2-Hydroxybenzyl) Methylamine for Mediated c-Myc Ubiquitin-Proteasomal Degradation in Lung Cancer Cells
Authors
Keywords
-
Journal
MOLECULAR PHARMACOLOGY
Volume 98, Issue 2, Pages 130-142
Publisher
American Society for Pharmacology & Experimental Therapeutics (ASPET)
Online
2020-06-03
DOI
10.1124/mol.120.119719
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer statistics, 2019
- (2019) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Emerging Roles of C-Myc in Cancer Stem Cell-Related Signaling and Resistance to Cancer Chemotherapy: A Potential Therapeutic Target Against Colorectal Cancer
- (2019) Mohamed Elbadawy et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Mission Possible: Advances in MYC Therapeutic Targeting in Cancer
- (2019) Brittany L. Allen-Petersen et al. BIODRUGS
- Mitochondria as multifaceted regulators of cell death
- (2019) Florian J. Bock et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Treatment beyond four cycles of first line Platinum and Etoposide chemotherapy in real-life patients with stage IV Small Cell Lung Cancer: a retrospective study of the Merseyside and Cheshire Cancer network
- (2019) Mostafa Sallam et al. BMC Pulmonary Medicine
- Feasibility Technique of Low-passage In Vitro Drug Sensitivity Testing of Malignant Pleural Effusion from Advanced-stage Non-small Cell Lung Cancer for Prediction of Clinical Outcome
- (2019) CHANIDA VINAYANUWATTIKUN et al. ANTICANCER RESEARCH
- FBXW7: a critical tumor suppressor of human cancers
- (2018) Chien-Hung Yeh et al. Molecular Cancer
- c-Myc is a major determinant for antitumor activity of Aurora A kinase inhibitor MLN8237 in thyroid cancer
- (2018) Yiqi Li et al. THYROID
- Therapeutic Inhibition of Myc in Cancer. Structural Bases and Computer-Aided Drug Discovery Approaches
- (2018) Lavinia Carabet et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Integrative natural medicine inspired graphene nanovehicle-benzoxazine derivatives as potent therapy for cancer
- (2018) Naveen Kumar et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- Knockdown of c-Myc activates Fas-mediated apoptosis and sensitizes A549 cells to radiation
- (2017) Jing Zhang et al. ONCOLOGY REPORTS
- High expression of CIP2A protein is associated with tumor aggressiveness in stage I–III NSCLC and correlates with poor prognosis
- (2017) Geqi Cha et al. OncoTargets and Therapy
- MYC Deregulation in Primary Human Cancers
- (2017) Manpreet Kalkat et al. Genes
- Cancer statistics, 2016
- (2016) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Crystallographic, spectroscopic (FT-IR/FT-Raman) and computational (DFT/B3LYP) studies on 4,4′-diethyl-2,2′-[methylazanediylbis(methylene)]diphenol
- (2016) Worawat Wattanathana et al. JOURNAL OF MOLECULAR STRUCTURE
- Potential of apoptotic pathway-targeted cancer therapeutic research: Where do we stand?
- (2016) S Baig et al. Cell Death & Disease
- c-Myc plays part in drug resistance mediated by bone marrow stromal cells in acute myeloid leukemia
- (2015) Bing Xia et al. LEUKEMIA RESEARCH
- MYC, Metabolism, and Cancer
- (2015) Z. E. Stine et al. Cancer Discovery
- Metastatic non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2014) M. Reck et al. ANNALS OF ONCOLOGY
- Antagonism of SET Using OP449 Enhances the Efficacy of Tyrosine Kinase Inhibitors and Overcomes Drug Resistance in Myeloid Leukemia
- (2014) A. Agarwal et al. CLINICAL CANCER RESEARCH
- Attacking c-Myc: Targeted and Combined Therapies for Cancer
- (2014) Huilin Huang et al. CURRENT PHARMACEUTICAL DESIGN
- Crystal structure and novel solid-state fluorescence behavior of the model benzoxazine monomer: 3,4-Dihydro-3,6-dimethyl-1,3,2H-benzoxazine
- (2014) Worawat Wattanathana et al. JOURNAL OF MOLECULAR STRUCTURE
- Inhibition of c-Myc Overcomes Cytotoxic Drug Resistance in Acute Myeloid Leukemia Cells by Promoting Differentiation
- (2014) Xiao-Na Pan et al. PLoS One
- Targeting c-MYC by antagonizing PP2A inhibitors in breast cancer
- (2014) M. Janghorban et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- MYC Degradation
- (2014) A. S. Farrell et al. Cold Spring Harbor Perspectives in Medicine
- MYC Activation Is a Hallmark of Cancer Initiation and Maintenance
- (2014) M. Gabay et al. Cold Spring Harbor Perspectives in Medicine
- An Overview of MYC and Its Interactome
- (2014) M. Conacci-Sorrell et al. Cold Spring Harbor Perspectives in Medicine
- Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
- (2013) J. Vansteenkiste et al. ANNALS OF ONCOLOGY
- MYC on the Path to Cancer
- (2012) Chi V. Dang CELL
- Triggering Fbw7-Mediated Proteasomal Degradation of c-Myc by Oridonin Induces Cell Growth Inhibition and Apoptosis
- (2012) H.-L. Huang et al. MOLECULAR CANCER THERAPEUTICS
- The Effect of Alkali and Ce(III) Ions on the Response Properties of Benzoxazine Supramolecules Prepared via Molecular Assembly
- (2012) Attaphon Kaewvilai et al. MOLECULES
- SET oncoprotein overexpression in B-cell chronic lymphocytic leukemia and non-Hodgkin lymphoma: a predictor of aggressive disease and a new treatment target
- (2011) D. J. Christensen et al. BLOOD
- Novel Recovery of Nano-Structured Ceria (CeO2) from Ce(III)-Benzoxazine Dimer Complexes via Thermal Decomposition
- (2011) Chatchai Veranitisagul et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Ubiquitin becomes ubiquitous in cancer
- (2010) Dingding Shi et al. CANCER BIOLOGY & THERAPY
- Myc protein is stabilized by suppression of a novel E3 ligase complex in cancer cells
- (2010) S. H. Choi et al. GENES & DEVELOPMENT
- CIP2A Is Associated with Human Breast Cancer Aggressivity
- (2009) C. Come et al. CLINICAL CANCER RESEARCH
- Self termination of ring opening reaction ofp-substituted phenol-based benzoxazines: An obstructive effectviaintramolecular hydrogen bond
- (2009) Suwabun Chirachanchai et al. JOURNAL OF HETEROCYCLIC CHEMISTRY
- The Fbxw7/hCdc4 tumor suppressor in human cancer
- (2008) YingMeei Tan et al. CANCER LETTERS
- Multiple pathways regulated by the tumor suppressor PP2A in transformation
- (2008) Jukka Westermarck et al. TRENDS IN MOLECULAR MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now